Photo of Joseph F. Quinn, M.D.

Joseph F. Quinn M.D.

    • Professor of Neurology School of Medicine
    • Director OHSU Parkinson Center and Movement Disorders Program School of Medicine
    • Director, Portland VAMC Parkinson’s Disease Research, Education, and Clinical Center (PADRECC)
    • Neuroscience Graduate Program School of Medicine

Director of the OHSU Parkinson Center and Movement Disorder Program

Director of the Portland VAMC Parkinson’s Disease Research, Education, and Clinical Center (PADRECC)

Professor of Neurology, OHSU School of Medicine

Dr. Quinn is NIH and VA-funded to conduct translational research in neurodegenerative disease, including work with animal models, biomarkers, and clinical trials. His research focus is on cognitive decline in Parkinson’s disease and other neurodegenerative diseases.

Read more
  • Residency:

    • Neurology-Oregon Health & Science University, Portland
  • Fellowship:

    • Geriatric neurology-VAMC Portland

Publications

  • "Brain multiplexes reveal morphological connectional biomarkers fingerprinting late brain dementia states." Scientific Reports  In: , Vol. 8, No. 1, 4103, 01.12.2018.
  • "Centella asiatica attenuates hippocampal mitochondrial dysfunction and improves memory and executive function in β-amyloid overexpressing mice." Molecular and Cellular Neuroscience  In: , Vol. 93, 01.12.2018, p. 1-9.
  • "Safety and Tolerability of Multiple Ascending Doses of PRX002/RG7935, an Anti--Synuclein Monoclonal Antibody, in Patients with Parkinson Disease : A Randomized Clinical Trial." JAMA Neurology  In: , Vol. 75, No. 10, 01.10.2018, p. 1206-1214.
  • "Centella asiatica increases hippocampal synaptic density and improves memory and executive function in aged mice." Brain and Behavior  In: , Vol. 8, No. 7, e01024, 01.07.2018.
  • "CNS Langerhans cell histiocytosis : Common hematopoietic origin for LCH-associated neurodegeneration and mass lesions." Cancer  In: , Vol. 124, No. 12, 15.06.2018, p. 2607-2620.
  • "Sex differences in progression to mild cognitive impairment and dementia in Parkinson's disease." Parkinsonism and Related Disorders  In: , 01.01.2018.
  • "Lost in Translation? Finding Our Way to Effective Alzheimer's Disease Therapies." Journal of Alzheimer's Disease  In: , Vol. 64, No. s1, 01.01.2018, p. S33-S39.
  • "Associations between CSF cortisol and CSF norepinephrine in cognitively normal controls and patients with amnestic MCI and AD dementia." International Journal of Geriatric Psychiatry  In: , Vol. 33, No. 5, 01.01.2018, p. 763-768.
  • "The key role of T cells in Parkinson's disease pathogenesis and therapy." Parkinsonism and Related Disorders  In: , 01.01.2018.
  • "Cascaded Multi-view Canonical Correlation (CaMCCo) for Early Diagnosis of Alzheimer's Disease via Fusion of Clinical, Imaging and Omic Features." Scientific Reports  In: , Vol. 7, No. 1, 8137, 01.12.2017.
  • "Pattern Discovery in Brain Imaging Genetics via SCCA Modeling with a Generic Non-convex Penalty." Scientific Reports  In: , Vol. 7, No. 1, 14052, 01.12.2017.
  • "Analysis of extracellular RNA in cerebrospinal fluid." Journal of Extracellular Vesicles  In: , Vol. 6, No. 1, 1317577, 01.12.2017.
  • "Sex differences in the association of alcohol with cognitive decline and brain pathology in a cohort of octogenarians." Psychopharmacology  In: , 29.11.2017, p. 1-10.
  • "Centella asiatica : phytochemistry and mechanisms of neuroprotection and cognitive enhancement." Phytochemistry Reviews  In: , 20.09.2017, p. 1-34.
  • "The effects of noncoding aquaporin-4 single-nucleotide polymorphisms on cognition and functional progression of Alzheimer's disease." Alzheimer's and Dementia: Translational Research and Clinical Interventions  In: , Vol. 3, No. 3, 01.09.2017, p. 348-359.
  • "Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer's disease." Nature Genetics  In: , Vol. 49, No. 9, 01.09.2017, p. 1373-1384.
  • "Large-scale exploratory genetic analysis of cognitive impairment in Parkinson's disease." Neurobiology of Aging  In: , Vol. 56, 01.08.2017, p. 211.e1-211.e7.
  • "Cerebrospinal fluid biomarkers for Alzheimer's and vascular disease vary by age, gender, and APOE genotype in cognitively normal adults." Alzheimer's Research and Therapy  In: , Vol. 9, No. 1, 48, 03.07.2017.
  • "An alpha-synuclein MRM assay with diagnostic potential for Parkinson's disease and monitoring disease progression." Proteomics - Clinical Applications  In: , Vol. 11, No. 7-8, 1700045, 01.07.2017.
  • "Transethnic genome-wide scan identifies novel Alzheimer's disease loci." Alzheimer's and Dementia  In: , Vol. 13, No. 7, 01.07.2017, p. 727-738.
  • "Association of plasma neurofilament light with neurodegeneration in patients with Alzheimer disease." JAMA Neurology  In: , Vol. 74, No. 5, 01.05.2017, p. 557-566.
  • "Centella asiatica attenuates Aβ-induced neurodegenerative spine loss and dendritic simplification." Neuroscience Letters  In: , Vol. 646, 12.04.2017, p. 24-29.
  • "Mass-Spectrometry-Based Method to Quantify in Parallel Tau and Amyloid β 1-42 in CSF for the Diagnosis of Alzheimer's Disease." Journal of Proteome Research  In: , Vol. 16, No. 3, 03.03.2017, p. 1228-1238.
  • "Longitudinal measurement and hierarchical classification framework for the prediction of Alzheimer's disease." Scientific Reports  In: , Vol. 7, 39880, 12.01.2017.
  • "Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies : a retrospective analysis." The Lancet Neurology  In: , Vol. 16, No. 1, 01.01.2017, p. 1234.
  • "Association of perivascular localization of aquaporin-4 with cognition and Alzheimer disease in aging brains." JAMA Neurology  In: , Vol. 74, No. 1, 01.01.2017, p. 91-99.
  • "Common variant rs356182 near SNCA defines a Parkinson's disease endophenotype." Annals of Clinical and Translational Neurology  In: , Vol. 4, No. 1, 01.01.2017, p. 15-25.
  • "MicroRNAs in human cerebrospinal fluid as biomarkers for Alzheimer's disease." Journal of Alzheimer's Disease  In: , Vol. 55, No. 3, 2017, p. 1223-1233.
  • "Serum hepcidin levels, iron dyshomeostasis and cognitive loss in Alzheimer'S Disease." Aging and Disease  In: , Vol. 8, No. 2, 2017, p. 215-227.
  • "Prediction of Conversion to Alzheimer's Disease with Longitudinal Measures and Time-To-Event Data." Journal of Alzheimer's Disease  In: , Vol. 58, No. 2, 2017, p. 361-371.

Additional information

Edit profile